News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,769 Results
Type
Article (51492)
Company Profile (506)
Press Release (701759)
Multimedia
Podcasts (138)
Webinars (20)
Section
Business (211127)
Career Advice (2089)
Deals (36386)
Drug Delivery (125)
Drug Development (85567)
Employer Resources (175)
FDA (16940)
Job Trends (15299)
News (358105)
Policy (33764)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2797)
Academic (1)
Accelerated approval (35)
Adcomms (31)
Allergies (147)
Alliances (51835)
ALS (179)
Alzheimer's disease (1747)
Antibody-drug conjugate (ADC) (345)
Approvals (17168)
Artificial intelligence (557)
Autoimmune disease (166)
Automation (40)
Bankruptcy (377)
Best Places to Work (11919)
BIOSECURE Act (21)
Biosimilars (196)
Biotechnology (353)
Bladder cancer (163)
Brain cancer (61)
Breast cancer (666)
Cancer (5062)
Cardiovascular disease (420)
Career advice (1765)
Career pathing (38)
CAR-T (311)
CDC (49)
Celiac Disease (2)
Cell therapy (838)
Cervical cancer (37)
Clinical research (72491)
Collaboration (1825)
Company closure (4)
Compensation (1180)
Complete response letters (68)
COVID-19 (2852)
CRISPR (100)
C-suite (892)
Cystic fibrosis (152)
Data (6362)
Decentralized trials (2)
Denatured (41)
Depression (144)
Diabetes (507)
Diagnostics (6850)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (278)
Drug pricing (199)
Drug shortages (30)
Duchenne muscular dystrophy (245)
Earnings (91863)
Editorial (61)
Employer branding (21)
Employer resources (154)
Events (122412)
Executive appointments (1009)
FDA (20111)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1542)
Gene editing (218)
Generative AI (46)
Gene therapy (672)
GLP-1 (1022)
Government (4835)
Grass and pollen (6)
Guidances (384)
Healthcare (19421)
HIV (61)
Huntington's disease (48)
IgA nephropathy (87)
Immunology and inflammation (284)
Immuno-oncology (66)
Indications (111)
Infectious disease (3130)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (253)
Interviews (328)
IPO (17026)
IRA (53)
Job creations (3748)
Job search strategy (1471)
JPM (67)
Kidney cancer (17)
Labor market (85)
Layoffs (600)
Leadership (33)
Legal (8122)
Liver cancer (96)
Longevity (15)
Lung cancer (689)
Lymphoma (387)
Machine learning (44)
Management (59)
Manufacturing (832)
MASH (172)
Medical device (14015)
Medtech (14068)
Mergers & acquisitions (20445)
Metabolic disorders (1333)
Multiple sclerosis (167)
NASH (19)
Neurodegenerative disease (346)
Neuropsychiatric disorders (97)
Neuroscience (3052)
Neurotech (1)
NextGen: Class of 2026 (6855)
Non-profit (4654)
Now hiring (67)
Obesity (640)
Opinion (287)
Ovarian cancer (169)
Pain (205)
Pancreatic cancer (237)
Parkinson's disease (296)
Partnered (35)
Patents (507)
Patient recruitment (509)
Peanut (58)
People (60815)
Pharmaceutical (89)
Pharmacy benefit managers (30)
Phase 1 (22818)
Phase 2 (31919)
Phase 3 (23631)
Pipeline (5381)
Policy (302)
Postmarket research (2663)
Preclinical (9986)
Press Release (70)
Prostate cancer (247)
Psychedelics (56)
Radiopharmaceuticals (299)
Rare diseases (910)
Real estate (6160)
Recruiting (72)
Regulatory (25391)
Reports (52)
Research institute (2583)
Resumes & cover letters (363)
Rett syndrome (27)
RNA editing (21)
RSV (79)
Schizophrenia (156)
Series A (256)
Series B (202)
Service/supplier (11)
Sickle cell disease (105)
Special edition (26)
Spinal muscular atrophy (167)
Sponsored (43)
Startups (3835)
State (2)
Stomach cancer (20)
Supply chain (107)
Tariffs (87)
The Weekly (95)
Vaccines (1064)
Venture capital (95)
Weight loss (416)
Women's health (93)
Worklife (19)
Date
Today (22)
Last 7 days (632)
Last 30 days (2161)
Last 365 days (31018)
2026 (3570)
2025 (31402)
2024 (36669)
2023 (41367)
2022 (52663)
2021 (57165)
2020 (55396)
2019 (47954)
2018 (36139)
2017 (33593)
2016 (33047)
2015 (39131)
2014 (32929)
2013 (28283)
2012 (30299)
2011 (30734)
2010 (28849)
Location
Africa (781)
Alabama (89)
Alaska (7)
Arizona (321)
Arkansas (14)
Asia (41954)
Australia (7157)
California (11554)
Canada (3320)
China (1157)
Colorado (491)
Connecticut (496)
Delaware (341)
Europe (93056)
Florida (1703)
Georgia (359)
Hawaii (3)
Idaho (62)
Illinois (891)
India (66)
Indiana (526)
Iowa (24)
Japan (441)
Kansas (131)
Kentucky (41)
Louisiana (27)
Maine (83)
Maryland (1415)
Massachusetts (8451)
Michigan (327)
Minnesota (643)
Mississippi (5)
Missouri (130)
Montana (34)
Nebraska (29)
Nevada (122)
New Hampshire (83)
New Jersey (3073)
New Mexico (32)
New York (3030)
North Carolina (1550)
North Dakota (10)
Northern California (5611)
Ohio (339)
Oklahoma (21)
Oregon (45)
Pennsylvania (2313)
Puerto Rico (25)
Rhode Island (49)
South America (1172)
South Carolina (66)
South Dakota (1)
Southern California (4475)
Tennessee (175)
Texas (1787)
United States (41185)
Utah (340)
Vermont (1)
Virginia (271)
Washington D.C. (82)
Washington State (963)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
753,769 Results for "lineage cell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
January 6, 2026
·
8 min read
Press Releases
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 6, 2025
·
18 min read
Press Releases
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
September 9, 2025
·
7 min read
Press Releases
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
September 3, 2025
·
2 min read
Press Releases
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
October 31, 2025
·
3 min read
Press Releases
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
·
18 min read
Press Releases
Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
August 6, 2025
·
2 min read
Press Releases
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
June 5, 2025
·
7 min read
Business
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
February 5, 2026
·
1 min read
·
Tristan Manalac
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.
January 29, 2026
·
1 min read
·
Tristan Manalac
1 of 75,377
Next
